William MD

Dr. Irvin joined the Bon Secours Cancer Institute from faculty at the University of North Carolina where he developed a specialty in breast cancer. At North Carolina, he led a nationally recognized clinical trial on pharmacogenetic dosing of tamoxifen. His research interests include overcoming endocrine resistance in breast cancer, triple-negative breast cancer, and breast cancer in young women. He attended the University of Virginia for his undergraduate degree and received his medical degree from Virginia Commonwealth University School of Medicine. He completed his internal medicine residency from Virginia Commonwealth University. From there, Dr. Irvin completed a hematology and oncology fellowship at the University of North Carolina.

Dr. Irvin is board certified by the American Board of Internal Medicine in Internal Medicine, Medical Oncology, and Hematology. For the Bon Secours Cancer Institute, Dr. Irvin is the Director of Clinical Research and the Physician Site Leader for Medical Oncology. Originally from Richmond, Dr. Irvin, his wife, and three children are excited to be home in Virginia.